Postoperative chemotherapy may improve prognosis in unresectable gastric cancer.

Hanazaki, K; Sodeyama, H; Yokoyama, S; Sode, Y; Wakabayashi, M; Kawamura, N; Miyazaki, T; Otsuka, M

Hanazaki, K; Sodeyama, H; Yokoyama, S; Sode, Y; Wakabayashi, M; Kawamura, N; Miyazaki, T; Otsuka, M.

Affiliation

Hanazaki K; Department of Surgery, Nagano Red Cross Hospital, Wakasato, Japan.

J Clin Gastroenterol ; 26(4): 269-73, 1998 Jun.

Article in En | MEDLINE | ID: mdl-9649009

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Stomach Neoplasms/drug therapy; Stomach Neoplasms/surgery; Adenocarcinoma/drug therapy; Adenocarcinoma/mortality; Adenocarcinoma/surgery; Adenocarcinoma, Papillary/drug therapy; Adenocarcinoma, Papillary/mortality; Adenocarcinoma, Papillary/surgery; Chemotherapy, Adjuvant; Female; Humans; Male; Middle Aged; Palliative Care; Prognosis; Retrospective Studies; Stomach Neoplasms/mortality; Survival Rate; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Clin Gastroenterol Year: 1998 Document type: Article Affiliation country: Japan Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links